Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and Diabetes

Abstract

PurposeObesity is a major modifiable risk factor for cardiovascular disease. Bariatric surgery is considered to be the most effective treatment option for weight reduction in obese patients with and without type 2 diabetes (T2DM).ObjectiveTo evaluate changes in lipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction following Roux-en-Y bariatric surgery in obese patients with and without diabetes.Materials and methodsLipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction were measured in 37 obese patients with (n = 17) and without (n = 20) T2DM, before and 6 and 12 months after Roux-en-Y bariatric surgery. Two way between subject ANOVA was carried out to study the interaction between independent variables (time since surgery and presence of diabetes) and all dependent variables.ResultsThere was a significant effect of time since surgery on (large effect size) weight, body mass index (BMI), waist circumference, triglycerides (TG), small-dense LDL apolipoprotein B (sdLDL ApoB), HOMA-IR, CRP, MCP-1, ICAM-1, E-selectin, P-selectin, leptin, and adiponectin. BMI and waist circumference had the largest impact of time since surgery. The effect of time since surgery was noticed mostly in the first 6 months. Absence of diabetes led to a significantly greater reduction in total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol although the effect size was small to medium. There was a greater reduction in TG and HOMA-IR in patients with diabetes with a small effect size. No patients were lost to follow up.ConclusionLipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction improve mostly 6 months after bariatric surgery in obese patients with and without diabetes.Clinical Trial Registration, identifier: NCT02169518. .

Obesity: A critical risk factor in the COVID‐19 pandemic

“…The benefits of weight‐loss on complications of obesity, insulin resistance and systemic inflammation are well‐documented, especially after bariatric surgery 134‐136 . However, even short‐term small amounts of weight‐loss can show substantial metabolic benefits 137 .…”

M1 macrophage subtypes activation and adipocyte dysfunction worsen during prolonged consumption of a fructose-rich diet

“…AT excess is generated by the imbalance between calories intake and energy expenditure, where energy excess is stored mainly in AT, favoring its expansion. Obesity and overweight, especially abdominal fat accumulation, are major risk factors for a number of noncommunicable diseases including cardiovascular disorders, dyslipidemia, insulin resistance and certain cancers, among others [1][2][3][4][5].…”

The leptin to adiponectin ratio (LAR) is reduced by sleeve gastrectomy in adults with severe obesity: a prospective cohort study

“…Bariatric surgery to treat severe obesity leads to significant improvements in diabetes control 2 , cardiovascular risk 3,4 , microalbuminuria 5 and systemic inflammation 6 . However, the influence of bariatric surgery on insulin sensitivity is not well defined 7,8 , partly because quantifying insulin sensitivity can be challenging. For example, the hyperinsulinaemic-euglycaemic clamp allows precise measurement of insulin sensitivity in muscle and liver 9 but is a technically elaborate and expensive technique that is only available in specialized research units.…”